Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
XRHealth and Reducept Offer Patients Virtual Reality Therapy for Pain Management
XRHealth, the leader in extended reality and therapeutic applications, announced today that they are working with Reducept […]
Gloucestershire Hospitals NHS Foundation Trust Selects Hyland Healthcare for Enhanced Content Services Infrastructure
NHS Digital Aspirant Gloucestershire Hospitals NHS Foundation Trust (GHNHSFT) is moving a core element of its […]
Innova Medical Group Gifts £10m to Launch Global Pandemic Institute in Liverpool
Innova Medical Group, a global health innovator and the world’s largest provider of rapid antigen […]
AbbVie and REGENXBIO Announce Eye Care Collaboration
AbbVie (NYSE: ABBV) and REGENXBIO Inc. (Nasdaq: RGNX) today announced a partnership to develop and […]
Respiratory Monitoring Medtech Firm Appoints Global Expert Dr. Peter Small as Chief Medical Officer
Fast-growing AI Medtech company Hyfe has, today, announced the appointment of world-renowned Seattle-based physician and […]
Anocca Appoints Jacob Michlewicz as CFO
Anocca AB, a leader in unlocking the potential of T-cell immunotherapy to deliver transformative therapeutics, […]
binx health Adds Industry Leaders, Elizabeth Mora and Naomi Kelman to Board of Directors
binx health, a healthcare technology and diagnostics company that brings convenient care to the locations […]
Medable Hires Chief Strategy Officer to Expand Global Partner and Innovation Ecosystem for Decentralized Clinical Trials
Medable Inc., the leading cloud platform for patient-centered drug development, today announced the hiring of Dr. […]
Provepharm Life Solutions Raises €120 Million
Provepharm Life Solutions, a private French pharmaceutical company that finds new applications for well-known molecules, […]
ILC Therapeutics Announces Successful Completion of £3.5m Funding Round
ILC Therapeutics, a UK-based biotechnology company and pioneer in the discovery and development of a […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more